Major Players Bolster Dtc Genetic Testing Market Through Strategic Genetic Research Investments Industry Trends Gaining Momentum in the Global Direct-To-Consumer (DTC) Genetic Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Direct-To-Consumer (DTC) Genetic Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the direct-to-consumer (DTC) genetic testing market has witnessed substantial growth. It is projected to expand from $1.84 billion in 2024 to $2.14 billion in 2025, signifying a compound annual growth rate (CAGR) of 16.2%. This surge during the historical period can be linked to various factors such as interest in lineage and ancestry, health and fitness inclinations, marketing and consumer awareness, privacy and power over genetic information along with affordability and reachability.

Direct-To-Consumer (DTC) Genetic Testing Market Size Forecast: What's the Projected Valuation by 2029?
The market size of direct-to-consumer (DTC) genetic testing is projected to experience significant expansion in the coming years, reaching $3.9 billion in 2029 with a compound annual growth rate (CAGR) of 16.2%. The predicted growth during this forecast period is due to factors such as the broadening scope of test offerings, integration into personalized healare, partnerships with health and wellness sectors, advancements in genetic studies, and government backing and regulations. Key trends during this period will include the expansion of test offerings and panels, consumer education campaigns, regulatory observance and supervision, genomic data research contributions, and making it more cost-effective and accessible.

View the full report here:
https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

What Are the Drivers Transforming the Direct-To-Consumer (DTC) Genetic Testing Market?
The growing occurrence of illnesses and conditions that can be transferred genetically is anticipated to fuel the expansion of the direct-to-consumer (DTC) genetic testing market. A genetic disorder is a disease triggered by changes, or mutations, in someone's DNA, encompassing single-gene, multifactorial, and chromosomal disorders. Direct-to-consumer genetic tests enhance awareness about various genetic disorders, enabling predictions about health and offering individualized health information. This includes disease risk and other traits, aiding in efficient health and lifestyle choices to mitigate disease risk. For instance, the US-based National Library of Medicine (NLM) stated in April 2023 that an estimated 6.7 million Americans over the age of 65 will be afflicted with Alzheimer's dementia (AD) in 2023, a condition heavily impacted by genetics. This figure might escalate to 13.8 million by 2060, unless there are medical advancements to prevent, slow down, or cure AD. Consequently, the growing prevalence of diseases and disorders capable of genetic transmission is a driving factor in the expansion of the direct-to-consumer (DTC) genetic testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

What Long-Term Trends Will Define the Future of the Direct-To-Consumer (DTC) Genetic Testing Market?
Significant corporations in the direct-to-consumer (DTC) genetic testing market are prioritizing investment into genetic research in order to maintain their market prominence. Such investments serve as crucial financial support for these firms to carry out research, improve technology, broaden market penetration, assure regulatory compliance, and spur innovation. For example, in November 2022, Redcliffe Labs, a diagnostic and lab company based in India, revealed plans to invest an additional $10 million (approximately Rs 81 crore) to expand their genetic and specialized testing services. The objective of this investment is to further enhance the company's genetic testing skills, including sectors like prenatal, oncology, neurology, nephrology, and pharmacogenomics. The company has previously invested $6 million in genetics and specialized testing, and is emphasizing the application of next-generation technology in diagnostic services.

Which Segments in the Direct-To-Consumer (DTC) Genetic Testing Market Offer the Most Profit Potential?
The direct-to-consumer (DTC) genetic testing market covered in this report is segmented -

1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User

Subsegments:
1) By Carrier Testing: Autosomal Recessive Disorders, X-Linked Disorders
2) By Predictive Testing: Risk Assessment For Genetic Conditions, Adult-Onset Conditions
3) By Ancestry And Relationship Testing: Ancestry Composition Analysis, DNA Matching For Relationships
4) By Nutrigenomic Testing: Recommendations, Metabolism And Fitness Insights
5) By Other Types: Pharmacogenomic Testing, Health Trait Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8957&type=smp

Which Firms Dominate the Direct-To-Consumer (DTC) Genetic Testing Market by Market Share and Revenue in 2025?
Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme

Which Regions Offer the Highest Growth Potential in the Direct-To-Consumer (DTC) Genetic Testing Market?
North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report :
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8957

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.